iShares Breakthrough Environmental Solutions ETF ETEC 深 沪
等待开盘 09-12 09:30:00 美东时间
23.9039
+0.388
+1.65%
华盛通- 最 高23.9039
- 今 开23.59
- 成交量 116股
- 最 低 23.9039
- 昨 收 23.5155
- 总市值 382.46万
- 52周最高 23.9039
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 15.6686
- 委 比 20.00%
- 总股本 16.00万
- 历史最高 26.2636
- 量 比 0
- 振 幅 0.00%
- 历史最低 15.6686
- 每 手 1
- 风险率 1.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Valneva Partners With CSL Seqirus For Exclusive Marketing And Distribution Of Proprietary Vaccines In Germany, Beginning July 2025
Under the agreed terms, CSL Seqirus will start commercializing Valneva's single-dose chikungunya vaccine IXCHIQ from July 2025, and Valneva's Japanese Encephalitis vaccine IXIARO and cholera/ETEC1 vaccine DUKORAL from
06-26 13:35
龙源电力持续助力南非青年技能提升
近日，南非可再生能源技术中心（SARETEC）在开普敦开普半岛理工大学贝尔维尔校区举办风电技术培训项目结业典礼，14名来自不同背景的青年学员获得了风电技术员资格...
05-28 18:55
Allegro MicroSystems Board Deems ON Semiconductor's $6.9B Offer 'Inadequate'
Allegro MicroSystems receives offer from ON Semiconductor for $35.10/share, with an implied EV of $6.9B. Allegro deemed onsemi's proposal inadequate.
03-06 18:53
Immuron to Present at the Military Health System Research Symposium
MELBOURNE, Australia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Immuron Lim...
2023-08-14 06:00
Immuron Announced Monday First Patient Were Enrolled in Travelan Clinical Study
: Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce the first cohort of 30 participants have been enrolled into the clinical trial to
2023-07-25 17:00
Immuron股价上涨 FDA对制药开发类股真的很重要
澳洲生物制药公司Immuron(ASX:IMC;NASDAQ:IMRN)周一上午上涨71%，该公司宣布FDA将允许该公司继续推进其针对弯曲杆菌和肠毒性大肠杆菌...
2023-05-09 19:08
